Roy S. Herbst, MD, PhD, Chief of Medical Oncology and Associate Cancer Center Director for Translational Research at Yale Cancer Center and Smilow Cancer Hospital, has been selected as the 2020 Clinical Research Award recipient by the Association of Community Cancer Centers (ACCC) for significantly and positively impacting oncology patients, their families, and the broader oncology community. The ACCC is one of the largest education and advocacy organizations for the cancer care community.

“We’ve seen great research and treatment advances in lung cancer, including immunotherapy and targeted therapies that significantly delay disease recurrence, but there is more work to do,” said Herbst. “I am grateful to the Association of Community Cancer Centers for shining a light on the important fight against this deadly disease.”

“Dr. Herbst was selected for this award based on his distinguished and effective accomplishments in lung cancer research, having successfully integrated biology and laboratory research, team- based science, broad collaboration, and community, patient, public, and private partnerships that have served as a road map and role model for others,” said Randall A Oyer, MD, Medical Director, Oncology Program, Penn Medicine Lancaster General Health, and ACCC President. “The work of Dr. Herbst and his team has importantly led to the approval of several treatments that have revolutionized lung cancer care, improved patient survival, and changed patient expectations."

The award was presented to Herbst during a virtual ceremony today. The award presentation and remarks from Herbst can be found on the ACCC website

About Yale Cancer Center and Smilow Cancer Hospital Yale Cancer Center (YCC) is one of only 51 National Cancer Institute-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Cancer treatment for patients is available at Smilow Cancer Hospital through 13 multidisciplinary teams and at 15 Smilow Cancer Hospital Care Centers in Connecticut and Rhode Island. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.

About ACCC The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization of the cancer care community. Founded in 1974, ACCC is a powerful network of 25,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options and care delivery models continue to evolve, so has ACCC, adapting its resources to meet the changing needs of the entire oncology team. For more information, visit or follow the organization on social media. ACCC also delivers regular and timely content on its blog channel, ACCCBuzz and its podcast CANCER BUZZ.


                                                                                                  #  #  #